Abstract
Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction
| Original language | English |
|---|---|
| Pages (from-to) | 1637-1644 |
| Number of pages | 8 |
| Journal | Circulation |
| Volume | 133 |
| Issue number | 17 |
| DOIs | |
| Publication status | Published - Apr 26 2016 |
Fingerprint
Keywords
- amiodarone
- atrial fibrillation
- catheter ablation
- heart failure
ASJC Scopus subject areas
- Physiology (medical)
- Cardiology and Cardiovascular Medicine
Cite this
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device : Results From the AATAC Multicenter Randomized Trial. / Di Biase, Luigi; Mohanty, Prasant; Mohanty, Sanghamitra; Santangeli, Pasquale; Trivedi, Chintan; Lakkireddy, Dhanunjaya; Reddy, Madhu; Jais, Pierre; Themistoclakis, Sakis; Dello Russo, Antonio; Casella, Michela; Pelargonio, Gemma; Narducci, Maria Lucia; Schweikert, Robert; Neuzil, Petr; Sanchez, Javier; Horton, Rodney; Beheiry, Salwa; Hongo, Richard; Hao, Steven; Rossillo, Antonio; Forleo, Giovanni; Tondo, Claudio; Burkhardt, J. David; Haissaguerre, Michel; Natale, Andrea.
In: Circulation, Vol. 133, No. 17, 26.04.2016, p. 1637-1644.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
T2 - Results From the AATAC Multicenter Randomized Trial
AU - Di Biase, Luigi
AU - Mohanty, Prasant
AU - Mohanty, Sanghamitra
AU - Santangeli, Pasquale
AU - Trivedi, Chintan
AU - Lakkireddy, Dhanunjaya
AU - Reddy, Madhu
AU - Jais, Pierre
AU - Themistoclakis, Sakis
AU - Dello Russo, Antonio
AU - Casella, Michela
AU - Pelargonio, Gemma
AU - Narducci, Maria Lucia
AU - Schweikert, Robert
AU - Neuzil, Petr
AU - Sanchez, Javier
AU - Horton, Rodney
AU - Beheiry, Salwa
AU - Hongo, Richard
AU - Hao, Steven
AU - Rossillo, Antonio
AU - Forleo, Giovanni
AU - Tondo, Claudio
AU - Burkhardt, J. David
AU - Haissaguerre, Michel
AU - Natale, Andrea
PY - 2016/4/26
Y1 - 2016/4/26
N2 - Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction
AB - Background - Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. Methods and Results - This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction
KW - amiodarone
KW - atrial fibrillation
KW - catheter ablation
KW - heart failure
UR - http://www.scopus.com/inward/record.url?scp=84962124333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962124333&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.115.019406
DO - 10.1161/CIRCULATIONAHA.115.019406
M3 - Article
AN - SCOPUS:84962124333
VL - 133
SP - 1637
EP - 1644
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 17
ER -